North America Cystic Fibrosis Market from 2016 to 2022

North America Cystic Fibrosis Market from 2016 to 2022

ID: MRFR/HC/1961-SR | May 2017 | Region: Global | 10 pages

North America Cystic Fibrosis Market is projected to grow at a CAGR of 13.7% and is expected to reach US$ 8852.2 million by 2022. In North America Cystic Fibrosis Market, US captured largest market share in 2016.


North America Cystic Fibrosis is a fastest growing market. The North America market comprises of US and Canadian market. US is dominating market in this region. In North America, United States is one of the countries with highest incidence rates of cystic fibrosis. Every year more than 1000 cases are diagnosed with cystic fibrosis in U S. but due to continuous development of medicines the life expectancy of cystic fibrosis patients has been increased from last thirty years. Major relief to the patients diagnosed with cystic fibrosis are CFTR modular drugs which include Kalydeco and Orkambi. Treatment methods include medications, medical devices and other treatments


North America Cystic Fibrosis Market, By Country, 2016 & 2022 (%)

North America Cystic Fibrosis Market


North America Cystic Fibrosis market statistical report published by Market Research future contains a brief overview of North America Cystic Fibrosis market. By country, the market has been segmented as US and Canada. US commands the largest share and is expected to grow continuously during the forecasted period of 2016-2022. The report analyzed the North America Cystic Fibrosis market and presents systematic data of market share on the basis of segments and countries, and its growth rate for 2013 to 2016, along with forecast till 2022.


Market Research future through this report aims to provide understanding of the North America Cystic Fibrosis market on the basis of segments & countries, and also assists identification of ongoing trends along with anticipated growth during the forecasted period. For this report, extensive primary research was conducted to gain a deeper insight of the market performance. Various industry experts and Key Opinion Leaders (KOLs) were contacted and interviewed to get an idea of North America Cystic Fibrosis market.


 
List of Tables


TABLE 1       NORTH AMERICA CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($MILLION)


TABLE 2       NORTH AMERICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION)


TABLE 3       U.S. CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)


TABLE 4       CANADA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)


 


List of Figures


FIGURE 1         NORTH AMERICA CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 ($MILLION)


FIGURE 2         NORTH AMERICA CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%)


FIGURE 3         NORTH AMERICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION)


FIGURE 4         U.S. CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)


FIGURE 5         CANADA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION)


 

You May Also Be Interested In Our Statistical Reports